ProQR Therapeutics (PRQR) Convertible Debt (2013 - 2021)
ProQR Therapeutics (PRQR) posted Convertible Debt of $3.4 million for Q4 2013.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Convertible Debt (2013 - 2021) Analysis & Trends
ProQR Therapeutics has reported Convertible Debt for 1 years, with the latest figure at $3.4 million in Q4 2013.
- Quarterly Convertible Debt changed N/A year-over-year to $3.4 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $3.4 million (changed N/A YoY) and the FY2013 annual result came in at $3.3 million, changed N/A from the prior year.
- Convertible Debt held at $3.4 million in Q4 2013 per PRQR's latest filing.
- Over five years, Convertible Debt peaked at $3.4 million in Q4 2013 and troughed at $3.4 million in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 218.57 Mn | 82.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 17,169.56 |
| Dec 31, 2020 | 16,467.91 Bn |
| Dec 31, 2019 | 2,737.33 |
| Mar 31, 2019 | 2.85 |
| Dec 31, 2018 | 2,035.11 |
| Sep 30, 2018 | 1.33 |
| Dec 31, 2017 | 779.46 |
| Dec 31, 2013 | 3.42 Mn |